Products

SARS-CoV-1 and MERS-CoV Research Tools

GeneCopoeia provides OmicsLink™ Expression-Ready ORF cDNA clones, lentiviral particles and AAV particles that express the viral proteins from SARS-CoV-1 and MERS-CoV, the human pathogenic coronaviruses that caused the 2002 SARS and 2012 MERS disease...

COVID-19 Coronavirus Antigen Microarray

SARS-CoV-2 is a betacoronavirus that is the cause of the COVID-19 global pandemic that began in 2019. SARS-CoV-2 infection of humans typically stimulates a strong humoral immunity response, leading to the production of both neutralizing and binding antibodies....

COVID-19 Coronavirus Receptor Stable Cell Lines

[tab:General information] GeneCopoeia has produced HEK293T cell lines expressing ACE2 and TMPRSS2, two human host factors needed for efficient infection by SARS-CoV-2, the virus responsible for the COVID-19 pandemic. These cell lines express ACE2 and/or TMPRSS2 mRNA...

COVID-19 Coronavirus Lentiviral and AAV Solutions

[tab:General information] GeneCopoeia carries complete suites of state-of-the-art products for gene delivery using lentivirus and adenoassociated virus (AAV). GeneCopoeia's lentiviral solutions include: Lentiviral plasmids. Available for expressing ORF cDNAs, gene...

Reagents

GeneCopoeia, Inc. a U.S.-based functional genomics company founded in 1999, develops cutting edge products and services for genomics, proteomics, and molecular and cellular biology. With emphasis on...

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.